Q4 2024 Telus Corp Earnings Call Transcript
Key Points
- TELUS Corp (TU) achieved its third consecutive year of surpassing 1 million mobility and fixed customer additions, with over 1.2 million net new customer additions in 2024.
- The company reported strong TTech EBITDA growth of 7% in Q4 2024 and 5.5% for the full year, meeting its target range.
- TELUS Health achieved accelerated revenue growth of 10% in Q4, alongside a 20% growth in its EBITDA contribution.
- TELUS Agriculture and Consumer Goods reported revenue growth of 16%, marking eight consecutive quarters of record sales performance.
- The company is on track to achieve $427 million in annualized synergies from its LifeWorks acquisition by year-end 2025.
- Mobile phone ARPU declined by 3.6% in Q4 2024, reflecting ongoing competitive pressures in the market.
- Free cash flow for 2024 was approximately $2 billion, slightly below the target of $2.1 billion due to higher-than-expected cash impacts from contract assets and device financing.
- TELUS Corp (TU) expressed disappointment in its share price performance over the past year despite strong operational and financial metrics.
- The company's leverage ratio at the end of 2024 was 3.9 times, with a commitment to deleveraging to a net debt-to-EBITDA ratio of approximately 3 times by 2027.
- Higher financing costs impacted net income, mainly due to unrealized changes in virtual power purchase agreements and increased long-term debt interest rates.
Good day. Welcome to TELUS's 2024 Q4 earnings conference call. I'd like to introduce your speaker, Mr. Robert Mitchell. Please go ahead.
Hello, everyone. Thank you for joining us today. Our fourth-quarter 2024 results news release, MD&A, financial statements, and detailed supplemental investor information were posted to our website earlier this morning. On our call today, we will begin with remarks by Darren and Doug. In the Q&A portion, we will be joined by Zainul, Navin, Jason, and Tobias.
Briefly, prepared remarks, slides and answers to questions contain forward-looking statements. Actual results could vary from these statements. The assumptions on which they are based and the material risks that could cause them to differ are outlined in our public filings with Securities Commissions in Canada and the US, including fourth-quarter and annual 2024 MD&A.
With that, over to you, Darren.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
